SCHEMBL31609179

CSCC[C@@H]1NC(=O)[C@H](C(C)C)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCSC)NC(=O)[C@H](CC(C)C)NC1=O

nearest known ligand 0.61

Predicted protein targets (top 15)

	gene	UniProt	supporting neighbours	confidence
▸	HDAC3	O15379	2/20	0.61

▸	HDAC4	P56524	2/20	0.61

▸	HDAC1	Q13547	2/20	0.61

▸	HDAC7	Q8WUI4	2/20	0.61

▸	HDAC2	Q92769	2/20	0.61

▸	HDAC10	Q969S8	2/20	0.61

▸	HDAC11	Q96DB2	2/20	0.61

▸	HDAC8	Q9BY41	2/20	0.61

▸	HDAC6	Q9UBN7	2/20	0.61

▸	HDAC9	Q9UKV0	2/20	0.61

▸	HDAC5	Q9UQL6	2/20	0.61

▸	OPRM1	P35372	1/20	0.57

▸	OPRD1	P41143	1/20	0.57

▸	PDCD1	Q15116	1/20	0.56

▸	CD274	Q9NZQ7	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL31609176	0.94	HDAC3 (0.59)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31609180	0.93	HDAC3 (0.59)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24614245	0.88	HDAC3 (0.72)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL30833606	0.88	HDAC3 (0.72)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31332253	0.86	HDAC3 (0.58)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL24173210	0.85	HDAC3 (0.66)	HDAC3HDAC4HDAC1HDAC7HDAC2
Bq-123 SCHEMBL1290617	0.85	PDCD1 (0.60)	HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL31609178	0.85	HDAC4 (0.53)	HDAC4HDAC1HDAC8HDAC6
Bq-123 SCHEMBL11916897	0.85	PDCD1 (0.60)	HDAC3HDAC4HDAC1HDAC7HDAC2
Bq-123 SCHEMBL29388467	0.85	PDCD1 (0.60)	HDAC3HDAC4HDAC1HDAC7HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3746041-B1	USE OF CYCLIC PEPTIDES IN COSMETIC	SEDERMA SA (FR)	2025-06-04	—	—	EP	claimed
EP-3746041-B1	USE OF CYCLIC PEPTIDES IN COSMETIC	SEDERMA SA (FR)	2025-06-04	—	—	EP	disclosed